Delusion and Haematocrit abnormal

Summary:

Haematocrit abnormal is reported only by a few people with Delusion.

The study analyzes which people have Haematocrit abnormal with Delusion. It is created by eHealthMe based on 2 people who have Haematocrit abnormal and Delusion from the Food and Drug Administration (FDA), and is updated regularly.

What is Delusion?

Delusion (a false belief or opinion) is found to be associated with 913 drugs and 1,091 conditions by eHealthMe. Check the latest studies of Delusion.

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 280 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

On Jun, 19, 2026

2 people who have Delusion and Haematocrit Abnormal are studied.

Would you have Haematocrit abnormal when you have Delusion?

Gender of people who have Delusion and experienced Haematocrit Abnormal *:

female: 0.0 %
male: 100 %

Age of people who have Delusion and experienced Haematocrit Abnormal *:

Common co-existing conditions for these people *:

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 50.00%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 50.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Haemoglobin Abnormal: 2 people, 100.00%
White Blood Cell Count Abnormal: 1 person, 50.00%
Gamma-Glutamyltransferase Abnormal: 1 person, 50.00%
Arrhythmias (irregular heartbeat): 1 person, 50.00%
Blood Albumin Abnormal: 1 person, 50.00%
Blood Alkaline Phosphatase Abnormal: 1 person, 50.00%
Blood Bicarbonate Abnormal: 1 person, 50.00%
Blood Chloride Abnormal: 1 person, 50.00%
Blood Potassium Abnormal: 1 person, 50.00%
Blood Test Abnormal: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Delusion (36,893 reports)
Haematocrit abnormal (1,610 reports)

All the drugs that are associated with Haematocrit abnormal:

Haematocrit abnormal (280 drugs)

All the conditions that are associated with Haematocrit abnormal:

Haematocrit abnormal (595 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit abnormal and Delusion, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.